News
CVALF
1.520
0.00%
0.000
Covalon appoints Murray Miller as independent director
PUBT · 9h ago
COVALON ANNOUNCES APPOINTMENT OF NEW DIRECTOR AND DSU GRANTS
Reuters · 9h ago
Covalon Technologies reports Q2 results
Seeking Alpha · 05/21 16:15
Canada's Covalon Q2 revenue rises on U.S. vascular access, surgical consumables growth
Reuters · 05/21 11:09
Covalon FY26 Q2 net income more than doubles to $1.09 million; revenue rises 15% to $8.73 million
PUBT · 05/21 11:01
COVALON REPORTS 2026 SECOND QUARTER RESULTS
Reuters · 05/21 11:00
COVALON Q2 EPS CAD 0.04
Reuters · 05/21 11:00
COVALON Q2 GROSS MARGIN 61.5%
Reuters · 05/21 11:00
Covalon schedules conference call on Q2 fiscal 2026 results
PUBT · 05/14 17:00
Covalon reports strong engagement at Infusion Nurses Society annual meeting
PUBT · 04/15 21:30
Covalon to showcase VALGuard, CovaClear at Infusion Nurses Society annual meeting
Reuters · 04/10 19:23
Covalon FY2026 grants 97,674 deferred share units; DSUs vest in 12 months
Reuters · 03/27 21:03
Covalon held its annual general and special shareholder meeting; shares represented totaled 10.16 million, or 36.78%
Reuters · 03/26 11:00
Covalon Q1 FY2026 net income hits CAD 0.1 million
Reuters · 02/25 12:01
COVALON TECHNOLOGIES LTD - Q1 2026 REVENUE $6.89 MLN
Reuters · 02/25 12:00
COVALON REPORTS ON 2026 FIRST QUARTER RESULTS AND RECENT ACHIEVEMENTS AND HIGHLIGHTS
Reuters · 02/25 12:00
Covalon Partners With AVA and Dr. Nancy Moureau for IV Infection Prevention Webinar
Reuters · 02/19 21:18
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
Barchart · 02/19 15:15
Covalon Technologies Ltd. published an update to their financial calendar
Reuters · 02/19 12:01
Covalon Technologies Ltd. Publishes 2025 Annual Report
Reuters · 12/11/2025 12:23
More
Webull provides a variety of real-time CVALF stock news. You can receive the latest news about Covalon Technologies Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CVALF
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.